HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)
IceCure Medical (NASDAQ:ICCM – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research note issued on Friday,Benzinga reports. They currently have a $2.50 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 125.23% from the company’s previous close. IceCure Medical […]
IceCure Medical (NASDAQ:ICCM – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research note issued on Friday,Benzinga reports. They currently have a $2.50 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 125.23% from the company’s previous close. IceCure Medical […]
